Back to discover
Disease

Cholecystitis

Late-stage therapeutic developmentEmerging research
2
Publications
15
Clinical trials
2022
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

15 sponsors · 2 new · 1 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
15
All trials
4
Active
11
Late-stage
6
Completed
Late-stage studies
Recruiting
Recently completed

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20172022
Major themes4
  • Antibiotic Prophylaxis1
  • Cholecystitis1
  • Cholelithiasis1
  • Diabetes Mellitus, Type 21
Leading journals2
  • Gastrointestinal endoscopy1
  • JAMA internal medicine1
Leading researchers8
  • Acosta RD1
  • Agrawal D1
  • Bruining DH1
  • Chandrasekhara V1
  • DeWitt JM1
  • Eloubeidi MA1
  • Fanelli RD1
  • Faulx AL1
Affiliations (unnormalised)1
  • Key Laboratory of Endocrinology of the National Health Commission1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.